Vanguard Group Inc Palisade Bio, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.11 - $83.85 $21,345 - $16.3 Million	-194,051 Reduced 71.45%	77,553 $8,000
Q1 2022 May 13, 2022	BUY	$0.81 - $1.51 $22,691 - $42,301	28,014 Added 11.5%	271,604 $288,000
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.93 $13,580 - $22,711	5,779 Added 2.43%	243,590 $645,000
Q2 2021 Aug 13, 2021	BUY	$3.49 - $11.34 $829,960 - $2.7 Million	237,811 New	237,811 $968,000

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $254M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.